DAPATOP-10

DAPATOP-10 is a prescription medication containing 10 mg of Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It is designed to manage type 2 diabetes mellitus and offers additional benefits for heart and kidney health.

Key Benefits:

• Type 2 Diabetes Management: DAPATOP-10 helps lower blood glucose levels by promoting the excretion of excess glucose through urine.

• Cardiovascular Protection: It reduces the risk of hospitalization for heart failure in individuals with type 2 diabetes and established cardiovascular disease or multiple cardiovascular risk factors.

• Renal Health Support: DAPATOP-10 slows the progression of chronic kidney disease and reduces the risk of end-stage kidney disease.

Mechanism of Action:

Dapagliflozin works by inhibiting the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose back into the bloodstream. By blocking this protein, DAPATOP-10 increases glucose excretion in urine, thereby lowering blood sugar levels.

Dosage and Administration:

• Dosage: The recommended dose is 10 mg once daily, taken orally.

• Administration: DAPATOP-10 can be taken with or without food. It is advisable to take it at the same time each day to maintain consistent blood levels.

Precautions and Warnings:

• Renal Function: Assess renal function